Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to test the hypothesis that those with non-traditional work schedules (e.g. shift workers) have a higher cardio-metabolic risk than those with traditional work schedules (e.g. day workers), and that both accumulated sleep debt and the degree of circadian disruption predict the elevated cardio-metabolic risk. The findings of this research are expected to increase our understanding of physiologic tolerance to non-traditional work schedules and provide the basis for the development of methods for the early detection of adverse health effects and determine coping strategies for the millions of workers with non-traditional work schedules.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02901860
Study type Observational
Source University of Chicago
Contact
Status Completed
Phase
Start date January 2012
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT01672502 - Fire Fighter Fatigue Management Program: Operation Fight Fatigue N/A
Completed NCT02978053 - Light Treatment to Shift-working Nurses N/A
Completed NCT00786357 - Sleep Enhancement Training Study for Experienced Shiftworkers Phase 1
Completed NCT00786266 - Sleep Enhancement Training Study for Novice Shiftworkers Phase 1
Completed NCT00900159 - Effects of Daytime Eszopiclone Administration in Shift Workers N/A
Completed NCT01988129 - Fire Fighter Fatigue Management Program: Operation Healthy Sleep N/A
Terminated NCT03879044 - Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD) N/A
Completed NCT02541747 - Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors Phase 4
Completed NCT03153917 - Biological Rhythms Impact of 12 Hours Shift Work N/A
Recruiting NCT03956745 - Biomarkers for Circadian Timing in Healthy Adults
Active, not recruiting NCT03980340 - Breath Biomarkers for Sleep Loss and Circadian Timing
Completed NCT00078312 - Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder Phase 3
Recruiting NCT06231641 - The Effects of Lemborexant on the Ability to Sleep During Daytime Phase 2
Recruiting NCT04693182 - Health Promoting Work Schedules: The Effect of Abolishing Quick Returns N/A
Not yet recruiting NCT03087435 - Well-Being in Medical Residents in the HIBA
Terminated NCT01264913 - Cardiometabolic Risk of Shiftwork N/A
Completed NCT03813654 - Sleep and Circadian Treatments for Shift Workers N/A